Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00722
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy